Drug Pricing Reform Twists And Turns In The COVID-19 Era

By Frank Zhou, Sonia Khurana, & Julia Gaebler, Ph.D.

In late 2019, there was strong political momentum toward drug pricing reform, with an expectation of legislation in the first few months of 2020. In an uncommon display of bipartisanship, both the House and the Senate had drafted or passed relevant legislation with significant common ground.